Literature DB >> 15866604

Interleukin-1 receptor antagonist and interleukin-1 beta polymorphisms in women with recurrent miscarriage.

Sabah Linjawi1, Tin-Chiu Li, Susan Laird, Alexandra Blakemore.   

Abstract

Genotypes and allele distributions for the interleukin (IL)-1beta -511 C/T and the IL-1 receptor antagonist gene intron 2 tandem repeat polymorphisms were compared in 206 women with recurrent miscarriage and a control population. No significant differences were observed between the distributions of IL-1beta or IL-1 receptor antagonist gene alleles in either the recurrent miscarriage group as a whole or when divided according to the cause of recurrent miscarriage compared with controls, which suggests that variation in the IL-1 receptor antagonist gene and IL-1beta genes individually does not play a role in susceptibility to recurrent miscarriage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866604     DOI: 10.1016/j.fertnstert.2004.10.052

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Association of interleukin 1 receptor antagonist (IL1RN) gene polymorphism with recurrent pregnancy loss risk in the North Indian Population and a meta-analysis.

Authors:  Rohini Ravindran Nair; Anuradha Khanna; Kiran Singh
Journal:  Mol Biol Rep       Date:  2014-06-22       Impact factor: 2.316

2.  Elevated circulating IL-1beta and TNF-alpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome.

Authors:  Nicolaos Vitoratos; Constantinos Papadias; Emmanuel Economou; Evangelos Makrakis; Constantinos Panoulis; George Creatsas
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 3.  Association between Genetic Polymorphisms in Interleukin Genes and Recurrent Pregnancy Loss - A Systematic Review and Meta-Analysis.

Authors:  Meixiang Zhang; Jiawei Xu; Xiao Bao; Wenbin Niu; Linlin Wang; Linqing Du; Nan Zhang; Yingpu Sun
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.